Clinical Trial Update: Mucosal and Microbiota Changes During Acute Campylobacteriosis

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial investigates mucosal and microbiota changes during acute Campylobacteriosis in individuals with Irritable Bowel Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Campylobacteriosis
• Irritable Bowel Syndrome

Snippet

Sponsor: Mayo Clinic | Conditions: Irritable Bowel Syndrome | Status: RECRUITING